Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

The latest news, stories and exciting findings from across the Oxford cancer research community

University's RadCam library highlighted in yellow

New vaccines that aim to prevent cancer: Starting the conversation

Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.

Attendees networking in the Ashmolean at the OCION Launch in 2023

Celebrating two years of the Oxford Cancer Immuno - Oncology Network

Professor Tim Elliott, Co- Director of Oxford Cancer, launched the Oxford Cancer Immuno-Oncology Network (OCION) at the inaugural OCION Symposium in June 2023 [pictured]. With our third annual symposium due to take place this month, we look back at some of OCION’s key achievements.

Cells under a microscope

New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia

Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.

Oxford Cancer hosts the inaugural Oxford Liver Cancer Centre of Excellence Symposium

The first Oxford Liver Cancer Centre of Excellence Symposium took place on Thursday 22nd May in the Richard Doll Building.

Molecule enabling new leukaemia treatments discovered

Researchers at the Shi Lab have discovered a first-in-class LSD1 PROTAC degrader, which opens up new therapeutic paths for the treatment of acute myeloid leukaemia. PROTAC degraders are molecules that degrade proteins by using the cell’s own machinery, binding to both the target protein and an E3 ligase, which marks it for degradation by the proteasome.

Oxford Cancer shortlisted for Vice-Chancellor’s Award

The Oxford Cancer Team were finalists in the 'Excellence across Oxford' category at this year's Vice Chancellor's Awards.

Vice-Chancellor's Breakthrough Researcher Award for Dr Joshua Bull

The University honoured remarkable talent and dedication to excellence on Thursday 15 May as the winners of the Vice-Chancellor's Awards 2025 were announced. Congratulations to Dr Joshua Bull from the Mathematical Institute, who received the Breakthrough Researcher Award.

Professor Andrew McMichael elected to the US National Academy of Sciences

The National Academy of Sciences (NAS) in the US just announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.

Bowel Cancer highlighted in the body

New guidelines published for monitoring IBD patients to prevent bowel cancer

Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.

Oxford Cancer launches CRIS Cancer Clinical Career Fellow Award 2025

Together with the CRIS Cancer Foundation, Oxford Cancer has launched the CRIS Cancer Clinical Career Fellow Award 2025, a new opportunity for clinical academics aiming to integrate cancer research with medical practice. Designed to foster independent research careers, this fellowship offers funding of up to £74,600 annually for up to three years to support salaries, research expenses, and clinical activities.

Doctor looking at a skin blemish on a patient using doctors tools

New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.

Oxford city skyline

New vaccines that aim to prevent cancer: Starting the conversation

A joint event from the Centre for Personalised Medicine (CPM) & Oxford Centre for Cancer Early Detection and Prevention (OxCODE) on Monday 2nd June 2025.

CRUK funding for research into earlier detection of relapse in people with multiple myeloma

Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.

Bowel cancer cells in the colon

£5.5m Research Funding to Transform Bowel Cancer Care

Cancer Research UK and partners have today committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. The team will be co-led by Professor Simon Leedham from the Nuffield Department of Medicine at the University of Oxford.

Students at a lab bench using a pipette

Project submissions welcome for the DPhil in Cancer Science

The DPhil in Cancer Science is inviting PIs from across Oxford University’s medical, physical, engineering, data, and mathematical sciences to submit their project ideas for its 2026 intake.

Only use with OxPop activity story

Daily physical activity, even at light intensities, linked to lower cancer risk

A study led by researchers from Oxford Population Health has found that daily physical activity is linked to a lower risk of cancer. The number of steps taken daily may be more important for cancer risk than the intensity of activity.

Showcasing cutting edge-cancer research at the 12th Annual Oxford Cancer Symposium

The 12th Annual Oxford Cancer Symposium, supported by the CRUK Oxford Centre, took place this year on the 18th March at the University's Mathematical Institute.

Join the Laboratory Efficiency Assessment Framework!

From 2025, Cancer Research UK (CRUK) will require all new wet-lab grant applications to have sustainability accreditation. Join the Laboratory Efficiency Assessment Framework (LEAF) now for support in meeting these new requirements!

CRUK funding for therapeutic HPV vaccine to prevent HPV-associated cancers

Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.

Stock image of surgery from Getty Images

New biopsy technique found to improve prostate cancer detection

Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.

Load More